100 likes | 109 Views
Learn about my participation in two COST Actions: RADAM and Raman4Clinics, which aim to study radiation damage in biomolecular systems and develop Raman-based applications for clinical diagnosis. Benefit from networking, collaboration, funding, and access to research infrastructure.
E N D
Participation in COST Actions Fiona Lyng RESC, FOCAS Institute
COST Action P9 - RADAM – Radiation Damage in Biomolecular Systems Materials, Physical and Nanosciences • Start Nov 2003 • End Nov 2007 • Action Chair: Prof Nigel Mason, Open University, UK • 22 member countries: Austria; Belgium; Bulgaria; Czech Republic; Denmark; France; Germany; Greece; Hungary; Iceland; Ireland; Israel; Italy; Lithuania; Netherlands; Poland; Portugal; Serbia; Slovakia; Spain; Sweden; UK
RADAM Objective Study of the fundamental interaction processes for different types of incident radiation – from initial deposition of radiative energy to the formation of radiation damage in biological material. Working Groups • WG1: Electron and Biomolecular interactions. WG leader: D. Field • WG2: Ions and Biomolecular interactions. WG leader: T. Schlathölter • WG3: Radiation in physiological environments. WG leader: K.G. McGuigan • WG4: Theoretical developments for radiation damage. WG leader: N. Vaeck • WG5: Track structures in cells. WG leader: H. Paretzke
RADAM - activities • Meetings • Working Group meetings • STSMs
RADAM - my participation • Joined 2005 • MC member with Prof Kevin McGuiganRCSI • Participation in meetings • RADAM06, Groningen, June 2006 • RADAM07, Dublin, June 2007 • STSMs • hosted 2 young researchers from Bulgaria in RESC laboratory
COST Action BM1401 - Raman4Clinics – Raman based applications for clinical diagnosisBiomedicine and Molecular Biosciences • Start Dec 2014 • End Dec 2018 • Action Chair: Prof Juergen Popp, University Jena, Germany • 27 member countries: • Austria; Belgium; Croatia; Czech Republic; Denmark; Estonia; Finland; France; Germany; Greece; Iceland; Ireland; Israel; Italy; Lativia; Luxembourg; Netherlands; Norway; Poland; Portugal; Romania; Serbia; Slovenia; Spain; Switzerland; Turkey; UK
Raman4Clinics Objective To develop a collaborative network of top European experts working towards the progress of the emerging field of Raman-based applications for clinical diagnostics. Working Groups WG1: Therapeutic monitoring of anti-tumoral drugs and antibiotics in body fluids.WG leader: Prof.ValterSergo WG2: Diagnosis of infectious diseases by detection of microbial pathogens. WG leader: Prof.EvangelosGiamarellos-Bourboulis WG3: Cytopathology of single cells for cancer cell monitoring. WG leader: Prof Fiona Lyng WG4: Histopathology of cells and tissue sections and biopsies from cancerous and noncancerous pathologies. WG leader: Dr. Christoph Krafft WG5: Fiber optic endoscopy for in vivo assessment of cancer and atherosclerosis. WG leader: Dr. Catherine Kendall WG6: Outreach to public and industry. WG leader: Prof Francesco Pavone
Raman4Clinics - activities • Meetings • 1st Scientific meeting, Florence, May 2015 • 2nd Scientific meeting, Jena, June 2016 • 3rd Scientific meeting, Belgrade, July 2017 • Final Scientific meeting, Coimbra, Oct 2018 • Working Group meetings • WG1 meeting, Trieste, Mar 2018 • WG2 meeting, Athens, June 2015 • WG3,4,5 meeting, Dublin, Mar 2016 • Summer schools • Jena, June 2016 • Coimbra, Oct 2018 • STSMs • Round robin
Raman4Clinics - my participation • Involved at proposal stage • Joined 2014 • MC member with Prof Tofail Syed, UL • WG3 leader • Participation in all meetings / organisation of WG3 sessions at all meetings • Reporting on WG3 activities at MC meetings • STSMs • FOCAS Institute hosted young researchers from France, Portugal, Iceland, UK • PhD student from RESC hosted at University of Reims, France
BENEFITS OF PARTICIPATION IN COST ACTIONS • Funding for Networking and Dissemination activities • Bottom up approach – any research field • Open to all COST countries • Anyone working in the area can join • Facilitates in depth discussions in a research area with experts in the field • Facilitates collaborations and access to different techniques / research infrastructure • Possible joint publications with other members • Possible to build a consortium for future research funding call